Westwood Holdings Group Inc Abbott Laboratories Transaction History

Westwood Holdings Group Inc

$12.8 Billion
Q1 2024

A detailed history of Westwood Holdings Group Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Westwood Holdings Group Inc holds 1,212,815 shares of ABT stock, worth $128 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares

1,212,815

Previous 1,212,815 -0.0%

Holding current value

$128 Million

Previous $138 Million -0.0%

% of portfolio

1.08%

Previous 1.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $12.9 Million - $14.2 Million	-117,602 Reduced 8.84%	1,212,815 $138 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $2.81 Million - $3.45 Million	31,211 Added 2.4%	1,330,417 $146 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $35.7 Million - $42.8 Million	373,317 Added 40.32%	1,299,206 $126 Million
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $66.3 Million - $73.8 Million	657,447 Added 244.91%	925,889 $101 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $270,045 - $317,859	-2,788 Reduced 1.03%	268,442 $27.2 Million

Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $113,121 - $132,708	-1,190 Reduced 0.44%	271,230 $29.8 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $222,548 - $257,669	-2,300 Reduced 0.84%	272,420 $26.4 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $1.06 Million - $1.28 Million	-10,356 Reduced 3.63%	274,720 $29.8 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $280,489 - $342,038	2,460 Added 0.87%	285,076 $33.7 Million
Q4 2021 Feb 25, 2022	SELL	$115.53 - $141.46 $503,479 - $616,482	-4,358 Reduced 1.52%	282,616 $39.8 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $612,814 - $677,952	-5,253 Reduced 1.8%	286,974 $33.9 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $60.3 Million - $70.9 Million	-569,608 Reduced 66.09%	292,227 $33.9 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $768,083 - $904,919	-7,057 Reduced 0.81%	861,835 $103 Million
Q4 2020 Apr 13, 2021	BUY	$105.0 - $114.42 $381,465 - $415,687	3,633 Added 0.42%	868,892 $95.1 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $29.7 Million - $32.4 Million	-283,215 Reduced 24.66%	865,259 $94.7 Million
Q3 2020 Nov 10, 2020	BUY	$91.64 - $111.29 $24.2 Million - $29.3 Million	263,635 Added 29.79%	1,148,474 $125 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $12.7 Million - $16.3 Million	-166,141 Reduced 15.81%	884,839 $80.9 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $5.35 Million - $7.82 Million	-85,135 Reduced 7.49%	1,050,980 $82.9 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $504,034 - $561,108	6,420 Added 0.57%	1,136,115 $98.7 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $988,136 - $1.07 Million	-12,074 Reduced 1.06%	1,129,695 $94.5 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $81.9 Million - $95.5 Million	-1,123,727 Reduced 49.6%	1,141,769 $96 Million
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $17.1 Million - $20.7 Million	-258,707 Reduced 10.25%	2,265,496 $181 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $53.7 Million - $60.9 Million	-819,728 Reduced 24.51%	2,524,203 $183 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $11.8 Million - $14.2 Million	-193,426 Reduced 5.47%	3,343,931 $245 Million
Q2 2018 Aug 13, 2018	BUY	$57.57 - $63.54 $5.74 Million - $6.34 Million	99,737 Added 2.9%	3,537,357 $216 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $3.09 Million - $3.5 Million	-54,974 Reduced 1.57%	3,437,620 $206 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $1.86 Million - $1.99 Million	-34,586 Reduced 0.98%	3,492,594 $199 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $170 Million - $189 Million	3,527,180	3,527,180 $188 Million

Others Institutions Holding ABT

# of Institutions

3,127

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $185B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westwood Holdings Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Westwood Holdings Group Inc with notifications on news.

Account

Westwood Holdings Group Inc Abbott Laboratories Transaction History